Exponent, Inc. (NASDAQ:EXPO) Shares Bought by Charles Schwab Investment Management Inc.

Charles Schwab Investment Management Inc. increased its stake in Exponent, Inc. (NASDAQ:EXPO) by 1.5% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 525,378 shares of the business services provider’s stock after purchasing an additional 7,766 shares during the period. Charles Schwab Investment Management Inc. owned 1.04% of Exponent worth $46,811,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors also recently bought and sold shares of EXPO. JPMorgan Chase & Co. lifted its stake in Exponent by 63.6% during the 3rd quarter. JPMorgan Chase & Co. now owns 630,644 shares of the business services provider’s stock valued at $72,701,000 after acquiring an additional 245,086 shares during the period. Geode Capital Management LLC lifted its stake in Exponent by 4.8% during the 3rd quarter. Geode Capital Management LLC now owns 1,505,652 shares of the business services provider’s stock valued at $173,597,000 after acquiring an additional 69,099 shares during the period. Barclays PLC lifted its stake in Exponent by 219.0% during the 3rd quarter. Barclays PLC now owns 96,526 shares of the business services provider’s stock valued at $11,127,000 after acquiring an additional 66,263 shares during the period. TimesSquare Capital Management LLC lifted its stake in Exponent by 22.4% during the 4th quarter. TimesSquare Capital Management LLC now owns 342,850 shares of the business services provider’s stock valued at $30,548,000 after acquiring an additional 62,760 shares during the period. Finally, DF Dent & Co. Inc. lifted its stake in Exponent by 26.8% during the 3rd quarter. DF Dent & Co. Inc. now owns 225,394 shares of the business services provider’s stock valued at $25,983,000 after acquiring an additional 47,573 shares during the period. 92.37% of the stock is currently owned by institutional investors and hedge funds.

Exponent Price Performance

NASDAQ:EXPO opened at $82.73 on Friday. The firm has a market cap of $4.20 billion, a price-to-earnings ratio of 39.02 and a beta of 0.77. The company has a 50 day moving average price of $88.54 and a 200-day moving average price of $97.48. Exponent, Inc. has a 1-year low of $77.27 and a 1-year high of $115.75.

Exponent (NASDAQ:EXPO) last posted its earnings results on Thursday, February 6th. The business services provider reported $0.46 earnings per share for the quarter, beating the consensus estimate of $0.40 by $0.06. Exponent had a net margin of 19.52% and a return on equity of 27.27%. During the same quarter last year, the business posted $0.41 earnings per share. On average, sell-side analysts anticipate that Exponent, Inc. will post 1.98 earnings per share for the current fiscal year.

Exponent Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, March 21st. Stockholders of record on Friday, March 7th will be issued a dividend of $0.30 per share. This represents a $1.20 annualized dividend and a dividend yield of 1.45%. This is a positive change from Exponent’s previous quarterly dividend of $0.28. The ex-dividend date is Friday, March 7th. Exponent’s payout ratio is 56.60%.

Insider Activity

In other Exponent news, VP Richard Reiss sold 1,736 shares of the company’s stock in a transaction on Wednesday, February 26th. The shares were sold at an average price of $85.93, for a total transaction of $149,174.48. Following the completion of the transaction, the vice president now directly owns 1,800 shares in the company, valued at approximately $154,674. This represents a 49.10 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Insiders own 2.10% of the company’s stock.

Exponent Company Profile

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.